Julie Dorney
Psychiatry · Atlanta, GANPI 1972713998
Payments from drug & device makers
Across 442 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$780
- Supernus Pharmaceuticals, Inc.$730
- Otsuka America Pharmaceutical, Inc.$713
- Lundbeck LLC$623
- Axsome Therapeutics, Inc.$454
- plus $4K from 27 others
What the payments were for
- Food & beverage$8,20699%
- Education$511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $1,138 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $780 |
| Supernus Pharmaceuticals, Inc. | 31 | $730 |
| Otsuka America Pharmaceutical, Inc. | 37 | $713 |
| Lundbeck LLC | 34 | $623 |
| Axsome Therapeutics, Inc. | 17 | $454 |
| Johnson & Johnson | 22 | $423 |
| Sunovion Pharmaceuticals Inc. | 24 | $382 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $344 |
| Tris Pharma Inc | 16 | $326 |
| Bausch Health US, LLC | 16 | $312 |
| Ironshore Pharmaceuticals Inc. | 15 | $310 |
| Corium, LLC | 14 | $296 |
| Neurocrine Biosciences, Inc. | 13 | $222 |
| Neos Therapeutics, LP | 13 | $212 |
| Noven Therapeutics, LLC | 8 | $175 |
| Teva Pharmaceuticals USA, Inc. | 8 | $136 |
| Collegium Pharmaceutical, Inc. | 5 | $102 |
| Shire North American Group Inc | 5 | $99 |
| Adlon Therapeutics L.p. | 4 | $67 |
| Merck | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Alfasigma USA, Inc. | 3 | $45 |
| Eisai Inc. | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Noven Pharmaceuticals, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Brainsway USA Inc | 1 | $10 |
How this compares
$8,257 in reported general payments places this provider in the 85th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 24 | $23,883 |
| Modafinil | 11 | $15,500 |
| Risperidone ErRisperidone Microspheres | 13 | $10,865 |
| Aripiprazole | 44 | $7,736 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $5,902 |
| Duloxetine Hcl | 100 | $2,032 |
| KlonopinClonazepam | 15 | $1,943 |
| Quetiapine Fumarate | 81 | $1,939 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 67 | $1,582 |
| Bupropion XlBupropion Hcl | 53 | $1,402 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 31 | $1,304 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $1,230 |
| Eszopiclone | 69 | $1,199 |
| Dextroamphetamine Sulfate | 15 | $1,196 |
| Trazodone Hcl | 86 | $837 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $344 | $29,78537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Atlanta
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Bethany DavisAtlanta$4.4M
- Patricio Riva PosseAtlanta$884K
- Kerry ResslerAtlanta$365K
- Boadie DunlopAtlanta$345K
- Michael BurkeAtlanta$328K
- Bryon EvansAtlanta$211K
- Nurul HoqueAtlanta$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.